We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNT
2101
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.18M | ﹤0.01% |
437,034
+23,498
| +6% | +$174K |
|
2102
eHealth
EHTH
$43.9M
| $3.17M | ﹤0.01% |
339,006
+257,110
| +314% | +$2.02M |
|
2103
CNA Financial
CNA
$14.1B
| $3.17M | ﹤0.01% |
81,286
+6,136
| +8% | +$257K |
|
|
RNAM
2104
DELISTED
Avidity Biosciences
RNAM
| $3.17M | ﹤0.01% |
206,437
+28,617
| +16% | +$630K |
|
2105
Energy Transfer Partners
ET
$69.3B
| $3.17M | ﹤0.01% |
254,034
-5,057
| -2% | -$63.9K |
|
2106
Hope Bancorp
HOPE
$1.79B
| $3.16M | ﹤0.01% |
321,668
-34,765
| -10% | -$426K |
|
2107
Destination XL Group
DXLG
$35.4M
| $3.16M | ﹤0.01% |
573,101
+372,731
| +186% | +$2.36M |
|
|
NGM
2108
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $3.14M | ﹤0.01% |
768,884
+11,131
| +1% | +$51.4K |
|
2109
iShares Russell 2000 ETF
IWM
$83B
| $3.14M | ﹤0.01% |
17,580
-65,242
| -79% | -$12M |
|
|
CIR
2110
DELISTED
CIRCOR International, Inc
CIR
| $3.11M | ﹤0.01% |
100,076
+24,509
| +32% | +$670K |
|
|
PSTL
2111
Postal Realty Trust
PSTL
$699M
| $3.11M | ﹤0.01% |
204,534
-68,991
| -25% | -$1.03M |
|
2112
FuelCell Energy
FCEL
$1.63B
| $3.11M | ﹤0.01% |
36,355
-3,492
| -9% | -$344K |
|
2113
Telephone and Data Systems
TDS
$3.75B
| $3.1M | ﹤0.01% |
295,238
-79,118
| -21% | -$923K |
|
2114
GFL Environmental
GFL
$14.9B
| $3.1M | ﹤0.01% |
+89,952
| New | +$2.84M |
|
2115
Ennis
EBF
$564M
| $3.1M | ﹤0.01% |
146,852
+6,646
| +5% | +$142K |
|
|
DSKE
2116
DELISTED
Daseke, Inc. Common Stock
DSKE
| $3.09M | ﹤0.01% |
399,929
+236,321
| +144% | +$1.74M |
|
|
SASR
2117
DELISTED
Sandy Spring Bancorp Inc
SASR
| $3.08M | ﹤0.01% |
118,609
-15,056
| -11% | -$484K |
|
2118
Hillman Solutions
HLMN
$1.79B
| $3.07M | ﹤0.01% |
365,026
-39,935
| -10% | -$347K |
|
|
PRA
2119
DELISTED
ProAssurance
PRA
| $3.07M | ﹤0.01% |
166,352
-16,012
| -9% | -$301K |
|
2120
Dillards
DDS
$9.56B
| $3.07M | ﹤0.01% |
9,973
-216
| -2% | -$76.8K |
|
2121
FB Financial Corp
FBK
$3.04B
| $3.07M | ﹤0.01% |
98,713
-10,937
| -10% | -$391K |
|
2122
SkinHealth Systems
SKIN
$85.7M
| $3.06M | ﹤0.01% |
242,649
-122,233
| -33% | -$1.41M |
|
|
NESR
2123
National Energy Services Reunited Corp
NESR
$2.93B
| $3.06M | ﹤0.01% |
581,550
-63,726
| -10% | -$421K |
|
2124
Monarch Casino & Resort
MCRI
$2.23B
| $3.06M | ﹤0.01% |
41,231
+5,425
| +15% | +$413K |
|
|
CDMO
2125
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $3.05M | ﹤0.01% |
162,592
-7,703
| -5% | -$127K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.